Chemours Co Stock Probability Of Bankruptcy
| CC Stock | USD 26.37 0.04 0.15% |
Chemours | Probability Of Bankruptcy |
Chemours Co Company probability of distress Analysis
Chemours' Probability Of Bankruptcy is a relative measure of the likelihood of financial distress. For stocks, the Probability Of Bankruptcy is the normalized value of Z-Score. For funds and ETFs, it is derived from a multi-factor model developed by Macroaxis. The score is used to predict the probability of a firm or a fund experiencing financial distress within the next 24 months. Unlike Z-Score, Probability Of Bankruptcy is the value between 0 and 100, indicating the firm's actual probability it will be financially distressed in the next 2 fiscal years.
More About Probability Of Bankruptcy | All Equity Analysis
Probability Of Bankruptcy | = | Normalized | | Z-Score |
Current Chemours Probability Of Bankruptcy | Less than 37% |
Most of Chemours' fundamental indicators, such as Probability Of Bankruptcy, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Chemours Co is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Our calculation of Chemours probability of bankruptcy is based on Altman Z-Score and Piotroski F-Score, but not limited to these measures. To be applied to a broader range of industries and markets, we use several other techniques to enhance the accuracy of predicting Chemours odds of financial distress. These include financial statement analysis, different types of price predictions, earning estimates, analysis consensus, and basic intrinsic valuation. Please use the options below to get a better understanding of different measures that drive the calculation of Chemours Co financial health.
Is Chemours' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Chemours. If investors know Chemours will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Chemours listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.91) | Dividend Share 1 | Earnings Share (1.60) | Revenue Per Share 40.473 | Quarterly Revenue Growth 0.017 |
The market value of Chemours is measured differently than its book value, which is the value of Chemours that is recorded on the company's balance sheet. Investors also form their own opinion of Chemours' value that differs from its market value or its book value, called intrinsic value, which is Chemours' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Chemours' market value can be influenced by many factors that don't directly affect Chemours' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Chemours' value and its price as these two are different measures arrived at by different means. Investors typically determine if Chemours is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Chemours' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Chemours Probability Of Bankruptcy Driver Correlations
Understanding the fundamental principles of building solid financial models for Chemours is extremely important. It helps to project a fair market value of Chemours Stock properly, considering its historical fundamentals such as Probability Of Bankruptcy. Since Chemours' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Chemours' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Chemours' interrelated accounts and indicators.
Click cells to compare fundamentals
The Probability of Bankruptcy SHOULD NOT be confused with the actual chance of a company to file for chapter 7, 11, 12, or 13 bankruptcy protection. Macroaxis simply defines Financial Distress as an operational condition where a company is having difficulty meeting its current financial obligations towards its creditors or delivering on the expectations of its investors. Macroaxis derives these conditions daily from both public financial statements as well as analysis of stock prices reacting to market conditions or economic downturns, including short-term and long-term historical volatility. Other factors taken into account include analysis of liquidity, revenue patterns, R&D expenses, and commitments, as well as public headlines and social sentiment.
| Competition |
Based on the latest financial disclosure, Chemours Co has a Probability Of Bankruptcy of 37.0%. This is 16.55% lower than that of the Chemicals sector and 11.46% lower than that of the Materials industry. The probability of bankruptcy for all United States stocks is 7.11% higher than that of the company.
Chemours Probability Of Bankruptcy Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Chemours' direct or indirect competition against its Probability Of Bankruptcy to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Chemours could also be used in its relative valuation, which is a method of valuing Chemours by comparing valuation metrics of similar companies.Chemours is currently under evaluation in probability of bankruptcy category among related companies.
Chemours Main Bankruptcy Drivers
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Return On Assets | (0.007165) | 0.0309 | 0.0805 | 0.0757 | (0.0288) | (0.0274) | |
| Asset Turnover | 0.9 | 0.76 | 0.7 | 0.84 | 0.73 | 1.02 | |
| Gross Profit Margin | 0.28 | 0.3 | 0.19 | 0.22 | 0.24 | 0.26 | |
| Net Debt | 3.5B | 3.2B | 2.5B | 2.7B | 2.5B | 2.3B | |
| Total Current Liabilities | 1.5B | 1.4B | 1.9B | 1.9B | 2.5B | 1.8B | |
| Non Current Liabilities Total | 5.0B | 4.8B | 4.6B | 4.6B | 5.0B | 4.1B | |
| Total Assets | 7.3B | 7.1B | 7.6B | 7.6B | 8.3B | 7.5B | |
| Total Current Assets | 2.8B | 2.6B | 3.3B | 3.2B | 3.8B | 3.0B | |
| Total Cash From Operating Activities | 650M | 807M | 820M | 754M | 556M | 635.8M |
Chemours Fundamentals
| Return On Equity | -0.26 | |||
| Return On Asset | 0.0529 | |||
| Profit Margin | (0.04) % | |||
| Operating Margin | 0.07 % | |||
| Current Valuation | 7.03 B | |||
| Shares Outstanding | 148.88 M | |||
| Shares Owned By Insiders | 0.59 % | |||
| Shares Owned By Institutions | 76.97 % | |||
| Number Of Shares Shorted | 4.88 M | |||
| Price To Earning | 25.49 X | |||
| Price To Book | 5.35 X | |||
| Price To Sales | 0.65 X | |||
| Revenue | 6.03 B | |||
| Gross Profit | 1.62 B | |||
| EBITDA | 220 M | |||
| Net Income | (238 M) | |||
| Cash And Equivalents | 1.1 B | |||
| Cash Per Share | 7.73 X | |||
| Total Debt | 4.3 B | |||
| Debt To Equity | 2.94 % | |||
| Current Ratio | 1.82 X | |||
| Book Value Per Share | 4.96 X | |||
| Cash Flow From Operations | 556 M | |||
| Short Ratio | 1.37 X | |||
| Earnings Per Share | (1.60) X | |||
| Price To Earnings To Growth | 1.67 X | |||
| Target Price | 31.44 | |||
| Number Of Employees | 6.2 K | |||
| Beta | 2.02 | |||
| Market Capitalization | 3.93 B | |||
| Total Asset | 8.25 B | |||
| Retained Earnings | 1.78 B | |||
| Working Capital | 1.35 B | |||
| Current Asset | 2.3 B | |||
| Current Liabilities | 1.47 B | |||
| Annual Yield | 0.04 % | |||
| Five Year Return | 3.59 % | |||
| Net Asset | 8.25 B | |||
| Last Dividend Paid | 1.0 |
About Chemours Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Chemours Co's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Chemours using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Chemours Co based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Pair Trading with Chemours
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Chemours position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Chemours will appreciate offsetting losses from the drop in the long position's value.Moving against Chemours Stock
| 0.64 | DNMR | Danimer Scientific Financial Report 8th of May 2024 | PairCorr |
| 0.59 | ECL | Ecolab Inc Financial Report 7th of May 2024 | PairCorr |
| 0.58 | FEAM | 5E Advanced Materials Financial Report 9th of May 2024 | PairCorr |
| 0.56 | CMT | Core Molding Technologies Financial Report 14th of May 2024 | PairCorr |
| 0.51 | ASH | Ashland Global Holdings Financial Report 7th of May 2024 | PairCorr |
The ability to find closely correlated positions to Chemours could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Chemours when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Chemours - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Chemours Co to buy it.
The correlation of Chemours is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Chemours moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Chemours moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Chemours can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Chemours Piotroski F Score and Chemours Altman Z Score analysis. Note that the Chemours information on this page should be used as a complementary analysis to other Chemours' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Complementary Tools for Chemours Stock analysis
When running Chemours' price analysis, check to measure Chemours' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Chemours is operating at the current time. Most of Chemours' value examination focuses on studying past and present price action to predict the probability of Chemours' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Chemours' price. Additionally, you may evaluate how the addition of Chemours to your portfolios can decrease your overall portfolio volatility.
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios |
Is Chemours' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Chemours. If investors know Chemours will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Chemours listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.91) | Dividend Share 1 | Earnings Share (1.60) | Revenue Per Share 40.473 | Quarterly Revenue Growth 0.017 |
The market value of Chemours is measured differently than its book value, which is the value of Chemours that is recorded on the company's balance sheet. Investors also form their own opinion of Chemours' value that differs from its market value or its book value, called intrinsic value, which is Chemours' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Chemours' market value can be influenced by many factors that don't directly affect Chemours' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Chemours' value and its price as these two are different measures arrived at by different means. Investors typically determine if Chemours is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Chemours' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.